List of works - Lisa Argnani

90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years

scientific article published on 14 March 2016

A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.

scientific article published on 8 June 2018

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

scientific article

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

scientific article published on 02 May 2011

Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients

scientific article published on 22 December 2012

BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia

scientific article published on 20 June 2019

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin

scientific article

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

scientific article

Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

scientific article

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.

scientific article published on 24 December 2015

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

scientific article published on 06 March 2017

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

scientific article published on 03 May 2013

Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience

scientific article published on 16 February 2018

Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.

scientific article published on 18 September 2013

Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial

scientific article

Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.

scientific article

Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis

scientific article published on 23 March 2017

Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report

scientific article

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens

scientific article published on 05 December 2012

Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients

article

Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.

scientific article

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

scientific article published on 3 November 2009

Growth of Chinese Italian infants in the first 2 years of life

article

Hairy cell leukemia: allogeneic transplantation could be an optimal option in selected patients

High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

scientific article published on 9 November 2015

Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report

scientific article published on 04 April 2018

Impressive Response to Pixantrone after Allogeneic Transplant in a Multiple Relapsed Diffuse Large B-Cell Lymphoma

scientific article published on 21 April 2017

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

scientific article published on 22 September 2014

Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: bridge to transplant.

scientific article

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

scientific article published on 16 February 2016

Is it really possible to cure hairy cell leukemia patients only with frontline therapy?

scientific article published on 22 April 2014

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

scientific article published on 23 May 2017

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma.

scientific article

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

scientific article published on 3 August 2017

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

scientific article published on 19 April 2018

Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified

scientific article published on 19 April 2011

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice.

scientific article published on 19 November 2014

Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature.

scientific article published on 16 March 2016

Local versus systemic treatment for primary cutaneous B-cell lymphoma

scientific article published on 01 September 2010

Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

scientific article published on 2 August 2016

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).

scientific article published on 27 January 2012

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.

scientific article published on 26 April 2013

Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.

scientific article

Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series.

scientific article published on 14 December 2012

Outpatient experience with biosimilar filgrastim in patients with lymphoid neoplasm: Lessons from daily clinical practice

scientific article published on 10 November 2016

Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.

scientific article published on 18 September 2017

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients

scientific article

Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients

scientific article published on 07 May 2011

Primary ocular adnexal lymphomas: a retrospective study of 25 patients.

scientific article published in February 2013

Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.

scientific article

Reporting real-life experience with drugs in lymphoma patients

scientific article published on 21 March 2016

Role of autologous stem cell transplantation in T-cell lymphoma patients: a single institution retrospective analysis

scientific article published on 10 June 2014

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

scientific article published on 6 January 2016

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients

scientific article published on 5 March 2015

Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

article

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program

article

Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient

scientific article published on 04 February 2014

The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience

scientific article published on 08 June 2018

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

scientific article

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study.

scientific article

The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.

scientific article

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

scientific article

Weight status and body image perception in Italian children

scientific article published on February 2008

Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome

scientific article published on 01 August 2010

List of works by Lisa Argnani

90-yttrium-ibritumomab tiuxetan consolidation of fludarabine, mitoxantrone, rituximab in intermediate/high-risk follicular lymphoma: updated long-term results after a median follow-up of 7 years

A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report.

A phase II study on the role of gemcitabine plus romidepsin (GEMRO regimen) in the treatment of relapsed/refractory peripheral T-cell lymphoma patients

A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma

Allotransplant in relapsed or refractory aggressive T-cell lymphomas: retrospective monocentric analysis of 14 patients

BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin

Bortezomib as salvage treatment for heavily pretreated relapsed lymphoma patients: a multicenter retrospective study

Brentuximab Vedotin in Transplant-Naïve Relapsed/Refractory Hodgkin Lymphoma: Experience in 30 Patients

Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study.

Brentuximab vedotin in relapsed primary mediastinal large B-cell lymphoma: results from a phase 2 clinical trial

Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials

Clinical Features and Treatment Outcomes of Primary Cutaneous B-cell Lymphomas: A Thirty-year Experience

Collection of hematopoietic stem cells after previous radioimmunotherapy is feasible and does not impair engraftment after autologous stem cell transplantation in follicular lymphoma.

Combination of lenalidomide and rituximab in elderly patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 2 trial

Cutaneous T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.

Efficacy and safety of biosimilar epoetin alpha in patients with chronic lymphoid neoplasms and chemotherapy-induced anaemia: An observational, retrospective, monocentric analysis

Efficacy of idelalisib as bridge to allogeneic stem cell transplant in relapsed follicular lymphoma: a case report

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens

Fludarabine-Mitoxantrone-Rituximab regimen in untreated indolent non-follicular non-Hodgkin's lymphoma: experience on 143 patients

Fludarabine-mitoxantrone-rituximab regimen in untreated intermediate/high-risk follicular non-Hodgkin's lymphoma: experience on 142 patients.

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome.

Growth of Chinese Italian infants in the first 2 years of life

Hairy cell leukemia: allogeneic transplantation could be an optimal option in selected patients

High efficacy of the MACOP-B regimen in the treatment of adult Langerhans cell histiocytosis, a 20 year experience

Hodgkin lymphoma presenting with paraneoplastic myasthenia: a case report

Impressive Response to Pixantrone after Allogeneic Transplant in a Multiple Relapsed Diffuse Large B-Cell Lymphoma

Impressive response to pegylated liposomal doxorubicin after allogeneic transplantation in a multi-relapsed Hodgkin's lymphoma

Interesting activity of pegylated liposomal doxorubicin in primary refractory and multirelapsed Hodgkin lymphoma patients: bridge to transplant.

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

Is it really possible to cure hairy cell leukemia patients only with frontline therapy?

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma

Italian real life experience with ibrutinib: results of a large observational study on 77 relapsed/refractory mantle cell lymphoma.

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma

Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).

Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice.

Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: a case report and review of the literature.

Local versus systemic treatment for primary cutaneous B-cell lymphoma

Long-Term Responders After Brentuximab Vedotin: Single-Center Experience on Relapsed and Refractory Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma Patients

Long-term efficacy and toxicity results of the FLUMIZ trial (fludarabine and mitoxantrone followed by yttrium-90 ibritumomab tiuxetan in untreated follicular lymphoma).

Long-term efficacy of the combination of lenalidomide and rituximab in elderly relapsed/refractory diffuse large B-cell lymphoma patients.

Long-term outcome of patients with advanced-stage cutaneous T cell lymphoma treated with gemcitabine.

Non-hodgkin lymphomas presenting as soft tissue masses: a single center experience and meta-analysis of the published series.

Outpatient experience with biosimilar filgrastim in patients with lymphoid neoplasm: Lessons from daily clinical practice

Peripheral T-cell lymphomas: Focusing on novel agents in relapsed and refractory disease.

Phase II trial of short-course R-CHOP followed by 90Y-ibritumomab tiuxetan in previously untreated high-risk elderly diffuse large B-cell lymphoma patients

Primary bone lymphoma: evaluation of chemoimmunotherapy as front-line treatment in 21 patients

Primary ocular adnexal lymphomas: a retrospective study of 25 patients.

Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.

Reporting real-life experience with drugs in lymphoma patients

Role of autologous stem cell transplantation in T-cell lymphoma patients: a single institution retrospective analysis

Romidepsin in relapsed/refractory T-cell lymphomas: Italian experience and results of a named patient program.

Safety and efficacy of single-agent bendamustine after failure of brentuximab vedotin in patients with relapsed or refractory hodgkin's lymphoma: experience with 27 patients

Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin

Siltuximab in relapsed/refractory multicentric Castleman disease: Experience of the Italian NPP program

Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient

The Berlin-Frankfurt-Münster protocol for the upfront treatment of aggressive lymphomas: The Bologna experience

The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study.

The role of rituximab and positron emission tomography in the treatment of primary mediastinal large B-cell lymphoma: experience on 74 patients.

The treatment of primary mediastinal large B-cell lymphoma: a two decades monocentric experience with 98 patients

Weight status and body image perception in Italian children

Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome